2014 Annual Meeting | 7MS.002 - Parkinson's Disease Management: Pearls, Pitfalls, and Future Prospects

Date Friday 05/02/14

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) Melissa J. Nirenberg, MD, PhD, FAAN

Topic(s)

Learning Objectives Participants should be able to understand the major benefits and limitations of currently available Parkinson's disease therapies; optimize the medical management of patients with Parkinson's disease; explain some of the major myths and misconceptions about Parkinson's disease therapies; understand the efficacy and limitations of current treatments; recognize the common motor and nonmotor complications of Parkinson's disease therapy; implement strategies to minimize and mitigate motor and nonmotor complications of Parkinson's disease treatments; describe the unmet needs in Parkinson's disease management; explain the types of treatments for Parkinson's disease that are in the pipeline, and how they may address these unmet needs.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 07:10 AM		Treatment of Motor Symptoms of Parkinson's Disease and Motor Complications of Dopaminergic Therapy Hubert H. Fernandez, MD, FAAN
07:10 AM - 07:15 AM		Questions and Answers Hubert H. Fernandez, MD, FAAN
07:15 AM - 07:55 AM		Treatment of Nonmotor Symptoms of Parkinson's Disease and Nonmotor Complications of Dopaminergic Therapy Melissa J. Nirenberg, MD, PhD, FAAN
07:55 AM - 08:00 AM		Questions and Answers Melissa J. Nirenberg, MD, PhD, FAAN

Faculty Disclosures
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Melissa J. Nirenberg, MD, PhD, FAAN	The institution of Dr. Nirenberg has received research support from Department of Veterans Affairs,. The institution of Dr. Nirenberg has received research support from National Institutes of Health. Dr. Nirenberg has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson's Foundation.

��ɫ��

��ɫ��